Kevin Marsh

Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans.Todryk, S. M. Bejon, P. Mwangi, T. Plebanski, M. Urban, B. Marsh, K. Hill, A. V. Flanagan, K. L.
PLoS One, (2008). 3:e2027

Plasmodium falciparum antigenic variation. Mapping mosaic var gene sequences onto a network of shared, highly polymorphic sequence blocks.Bull, P. C. Buckee, C. O. Kyes, S. Kortok, M. M. Thathy, V. Guyah, B. Stoute, J. A. Newbold, C. I. Marsh, K.
Mol Microbiol, (2008). 68:1519-34

Promoting the social value of research in Kenya: examining the practical aspects of collaborative partnerships using an ethical framework.Lairumbi, G. M. Molyneux, S. Snow, R. W. Marsh, K. Peshu, N. English, M.
Soc Sci Med, (2008). 67:734-47

Longitudinal analyses of immune responses to Plasmodium falciparum derived peptides corresponding to novel blood stage antigens in coastal Kenya.Agak, G. W. Bejon, P. Fegan, G. Gicheru, N. Villard, V. Kajava, A. V. Marsh, K. Corradin, G.
Vaccine, (2008). 26:1963-71

Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria.Osier, F. H. Fegan, G. Polley, S. D. Murungi, L. Verra, F. Tetteh, K. K. Lowe, B. Mwangi, T. Bull, P. C. Thomas, A. W. Cavanagh, D. R. McBride, J. S. Lanar, D. E. Mackinnon, M. J. Conway, D. J. Marsh, K.
Infect Immun, (2008). 76:2240-8

Helminth infection and eosinophilia and the risk of Plasmodium falciparum malaria in 1- to 6-year-old children in a malaria endemic area.Bejon, P. Mwangi, T. W. Lowe, B. Peshu, N. Hill, A. V. Marsh, K.
PLoS Negl Trop Dis, (2008). 2:e164

Variation in use of erythrocyte invasion pathways by Plasmodium falciparum mediates evasion of human inhibitory antibodies.Persson, K. E. McCallum, F. J. Reiling, L. Lister, N. A. Stubbs, J. Cowman, A. F. Marsh, K. Beeson, J. G.
J Clin Invest, (2008). 118:342-51

Common variation in the ABO glycosyltransferase is associated with susceptibility to severe Plasmodium falciparum malaria.Fry, A. E. Griffiths, M. J. Auburn, S. Diakite, M. Forton, J. T. Green, A. Richardson, A. Wilson, J. Jallow, M. Sisay-Joof, F. Pinder, M. Peshu, N. Williams, T. N. Marsh, K. Molyneux, M. E. Taylor, T. E. Rockett, K. A. Kwiatkowski, D. P.
Hum Mol Genet, (2008). 17:567-76

Biphasic Clinical Course among Kenyan Children with Cerebral Malaria.Gwer, S. Punt, J. Idro, R. Mwamuye, A. Gatakaa, H. Charles, R. J. C. Marsh, K
African Journal of Neurological Sciences, (2008). 27:6-10

The decline in paediatric malaria admissions on the coast of Kenya.Okiro, E. A. Hay, S. I. Gikandi, P. W. Sharif, S. K. Noor, A. M. Peshu, N. Marsh, K. Snow, R. W.
Malar J, (2007). 6:151

Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting.Rowe, J. A. Handel, I. G. Thera, M. A. Deans, A. M. Lyke, K. E. Kone, A. Diallo, D. A. Raza, A. Kai, O. Marsh, K. Plowe, C. V. Doumbo, O. K. Moulds, J. M.
Proc Natl Acad Sci U S A, (2007). 104:17471-6

Clearing asymptomatic parasitaemia increases the specificity of the definition of mild febrile malaria.Bejon, P. Mwangi, T. Lowe, B. Peshu, N. Hill, A. V. Marsh, K.
Vaccine, (2007). 25:8198-202

Haemoglobin C and S role in acquired immunity against Plasmodium falciparum malaria.Verra, F. Simpore, J. Warimwe, G. M. Tetteh, K. K. Howard, T. Osier, F. H. Bancone, G. Avellino, P. Blot, I. Fegan, G. Bull, P. C. Williams, T. N. Conway, D. J. Marsh, K. Modiano, D.
PLoS One, (2007). 2:e978

The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum.Bejon, P. Mwacharo, J. Kai, O. Todryk, S. Keating, S. Lowe, B. Lang, T. Mwangi, T. W. Gilbert, S. C. Peshu, N. Marsh, K. Hill, A. V.
J Immunol, (2007). 179:4193-201

Defining childhood severe falciparum malaria for intervention studies.Bejon, P. Berkley, J. A. Mwangi, T. Ogada, E. Mwangi, I. Maitland, K. Williams, T. Scott, J. A. English, M. Lowe, B. S. Peshu, N. Newton, C. R. Marsh, K.
PLoS Med, (2007). 4:e251

Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.Bejon, P. Ogada, E. Mwangi, T. Milligan, P. Lang, T. Fegan, G. Gilbert, S. C. Peshu, N. Marsh, K. Hill, A. V.
PLoS One, (2007). 2:e707

Positive replication and linkage disequilibrium mapping of the chromosome 21q22.1 malaria susceptibility locus.Khor, C. C. Vannberg, F. O. Chapman, S. J. Walley, A. Aucan, C. Loke, H. White, N. J. Peto, T. Khor, L. K. Kwiatkowski, D. Day, N. Scott, A. Berkley, J. A. Marsh, K. Peshu, N. Maitland, K. Williams, T. N. Hill, A. V.
Genes Immun, (2007). 8:570-6

Naturally acquired antibodies to polymorphic and conserved epitopes of Plasmodium falciparum merozoite surface protein 3.Osier, F. H. Polley, S. D. Mwangi, T. Lowe, B. Conway, D. J. Marsh, K.
Parasite Immunol, (2007). 29:387-94

Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya.Cumberland, P. Shulman, C. E. Maple, P. A. Bulmer, J. N. Dorman, E. K. Kawuondo, K. Marsh, K. Cutts, F. T.
J Infect Dis, (2007). 196:550-7

Antibodies among men and children to placental-binding Plasmodium falciparum-infected erythrocytes that express var2csa.Beeson, J. G. Ndungu, F. Persson, K. E. Chesson, J. M. Kelly, G. L. Uyoga, S. Hallamore, S. L. Williams, T. N. Reeder, J. C. Brown, G. V. Marsh, K.
Am J Trop Med Hyg, (2007). 77:22-8